ROCKVILLE, Md., March 13 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Penny Heaton, Chief Medical Officer, will be presenting at the Cowen and Company 29th Annual Healthcare Conference at 8:45 a.m. on March 17, 2009 at the Boston Marriott Copley Place in Boston, MA. Dr. Heaton will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.
Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new, and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.
|SOURCE Novavax, Inc.|
Copyright©2009 PR Newswire.
All rights reserved